Difference between revisions of "Profile Strategy for Vol CT"
Jump to navigation
Jump to search
(New page: Vol CT needs to define a set of Profiles that ideally should: :* get something out soon and then build on it :* provide value starting with the first profile :* generate clinical interest...) |
(No difference)
|
Revision as of 07:57, 26 January 2009
Vol CT needs to define a set of Profiles that ideally should:
- get something out soon and then build on it
- provide value starting with the first profile
- generate clinical interest
- generate industry interest
Propose Profile Sets here and summarize the claim for each Profile:
Primary/Regional Nodes & Metastatic Sites Profile
- You will be able to ...
Primary, Hilar & Medistinal Lymph Nodes Profile
- You will be able to ...
Primary Tumor and Neo/Adjuvant Rx Profile
- You will be able to ...
Items to be considered from the January 12th, 2009 VolCT weekly call
- Proffered claims a la UPICT bulls-eye: What assertions can we make about the information in our images? What can the information do for us, and for our human research volunteers? For ordinary patients with cancer?
- Sequentially more complex and elegant tools/criteria/assertions?
- Expression of what our problem is: What change do we want to measure?
- Can we detect Progression of Disease prior to the detection of new lesions? Can we reduce the fraction of PD dx's based on new lesions?
- Claims need to be technical in nature, not medical in nature, not philosophical.
- Quality of information should become progressively more robust: bulls-eye model.
- Profile claims are distinct from profile details.
- Technical parameters of CT plus patient populations plus patient prep plus measurement/image analysis technique.